实用老年医学 ›› 2025, Vol. 39 ›› Issue (9): 963-967.doi: 10.3969/j.issn.1003-9198.2025.09.021

• 临床研究 • 上一篇    下一篇

人工智能与可穿戴设备在老年人静脉血栓栓塞防治中的研究进展

周丹, 魏可欣, 邓姝, 何锐   

  1. 400038 重庆市,陆军军医大学第一附属医院创伤关节外科
  • 收稿日期:2025-01-05 出版日期:2025-09-20 发布日期:2025-09-19
  • 通讯作者: 邓姝,Email: dengshu9624@tmmu.edu.cn

Research progress on the prevention and treatment of venous thromboembolism in elderly using artificial intelligence and wearable devices

ZHOU Dan, WEI Kexin, DENG Shu, HE Rui   

  1. Center for Joint Surgery, the First Affiliated Hospital of Army Medical University, Chongqing 400038, China
  • Received:2025-01-05 Online:2025-09-20 Published:2025-09-19
  • Contact: DENG Shu, Email: dengshu9624@tmmu.edu.cn

摘要: 随着全球人口老龄化的加剧,静脉血栓栓塞(VTE)在老年人群中的发病率显著上升,其防治面临诸多挑战,包括老年特异性风险因素的复杂性、传统评估工具的局限性等。本文系统综述了人工智能(AI)与可穿戴设备在老年VTE防治中的研究进展,在预测与预防方面,AI模型通过整合多源数据显著提升风险识别精度,AUC值达到0.88。智能鞋垫、毫米波雷达及柔性电子皮肤贴片等可穿戴设备,通过监测步态变异、下肢微动频率及温度梯度等生理指标,实现了对VTE的早期预警,并支持个性化干预措施的制定。在诊断与评估方面,手持床旁超声(POCUS)与可穿戴超声系统结合AI,提升了诊断的效率和准确性。基于电子健康记录(EHR)的决策支持工具和智能设备实时监测生理参数,优化了风险评估与健康管理策略。在治疗方面,AI技术可指导个体化抗凝策略的制定及下腔静脉滤器的循证决策,以及可穿戴设备的动态监测结合行为干预措施,均有效降低了VTE的发生率。尽管AI与可穿戴设备在老年VTE防治中潜力巨大,但数据隐私保护、老年群体技术接受度不同及医疗资源不均仍是主要的推广障碍,未来需构建整合多源数据的智能健康管理平台,强化隐私保护机制,优化设备的适老化设计,并通过多中心临床验证推动技术的转化和应用,以实现更高效、安全的老年VTE智能防治体系。

关键词: 人工智能, 可穿戴设备, 静脉血栓栓塞, 老年人, 个性化医疗

Abstract: With the aging of the global population, the incidence of venous thromboembolism (VTE) has increased significantly in the elderly population, and its prevention and treatment face many challenges, including the complexity of age-specific risk factors and the limitations of traditional assessment tools. This paper systematically reviews the research progress of artificial intelligence (AI) and wearable devices in the prevention and treatment of VTE in the elderly. In terms of prediction and prevention, the AI model significantly improves the accuracy of risk identification by integrating multi-source data, with an AUC value of 0.88. Wearable devices such as smart insoles, millimetre-wave radar, and flexible e-skin patch achieve the early detection of VTE through monitoring the physiological indexes such as gait variations, lower limb micromovement frequency, and temperature gradient, achieving early warning of VTE and supporting the development of personalised interventions. In terms of diagnosis and assessment, handheld bedside ultrasound (POCUS) and wearable ultrasound systems combined with AI have improved the efficiency and accuracy of diagnosis. Decision support tools based on electronic health records (EHR) and real-time physiological parameter monitoring by smart devices optimise risk assessment and health management strategies. On the therapeutic side, AI technology guides the development of individualised anticoagulation strategies and evidence-based decision-making for inferior vena cava filters, and dynamic monitoring of wearable devices combined with behavioural interventions effectively reduces the incidence of VTE. Although AI and wearable devices have great potential in the prevention and treatment of VTE in the elderly, data privacy protection, differences in the acceptance of technology in the elderly population, and uneven medical resources are still the main barriers to the promotion of the technology. In the future, it is necessary to build a smart health management platform integrating data from multiple sources, strengthen the privacy protection mechanism, optimize the aging-adapted design of the devices, and promote the translation and application of the technology through multicenter clinical validation, in order to achieve a more efficient and safe system of intelligent prevention and treatment for VTE in the elderly.

Key words: artificial intelligence, wearable devices, venous thromboembolism, aged, personalized medicine

中图分类号: